Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
11.1M
-
Shares change
-
-3.06M
-
Total reported value, excl. options
-
$13.7M
-
Value change
-
-$3.9M
-
Put/Call ratio
-
0
-
Number of buys
-
9
-
Number of sells
-
-38
-
Price
-
$1.23
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q3 2022
70 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q3 2022.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.1M shares
.
Largest 10 shareholders include Tieton Capital Management, LLC (2.28M shares), VANGUARD GROUP INC (2.23M shares), Yong Rong (HK) Asset Management Ltd (1.93M shares), ICONIQ Capital, LLC (1.3M shares), RENAISSANCE TECHNOLOGIES LLC (618K shares), GEODE CAPITAL MANAGEMENT, LLC (553K shares), BARCLAYS PLC (294K shares), MILLENNIUM MANAGEMENT LLC (201K shares), STATE STREET CORP (177K shares), and Ergoteles LLC (127K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.